Larson Financial Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $570K | Buy |
2,607
+384
| +17% | +$84K | 0.02% | 398 |
|
|
2025
Q1 | $498K | Buy |
2,223
+2,160
| +3,429% | +$484K | 0.02% | 408 |
|
|
2024
Q4 | $20.6K | Buy |
63
+59
| +1,475% | +$19.3K | ﹤0.01% | 1203 |
|
|
2024
Q3 | $1.2K | Buy |
4
+1
| +33% | +$300 | ﹤0.01% | 1936 |
|
|
2024
Q2 | $988 | Sell |
3
-27
| -90% | -$8.89K | ﹤0.01% | 1703 |
|
|
2024
Q1 | $11.9K | Hold |
30
| – | – | ﹤0.01% | 1000 |
|
|
2023
Q4 | $10.6K | Sell |
30
-8
| -21% | -$2.83K | ﹤0.01% | 1000 |
|
|
2023
Q3 | $14.3K | Buy |
38
+11
| +41% | +$4.14K | ﹤0.01% | 905 |
|
|
2023
Q2 | $10.4K | Hold |
27
| – | – | ﹤0.01% | 920 |
|
|
2023
Q1 | $9.38K | Hold |
27
| – | – | ﹤0.01% | 939 |
|
|
2022
Q4 | $6.37K | Hold |
27
| – | – | ﹤0.01% | 983 |
|
|
2022
Q3 | $7K | Buy |
+27
| New | +$7K | ﹤0.01% | 897 |
|